Cytotoxic effects of curcumin on osteosarcoma cell lines
- 11 December 2007
- journal article
- Published by Springer Science and Business Media LLC in Investigational New Drugs
- Vol. 26 (4), 289-297
- https://doi.org/10.1007/s10637-007-9099-7
Abstract
Curcumin (diferuloylmethane), one of the main components of the Indian spice turmeric, is known to possess potent anti-inflammatory and anti-oxidant properties. In addition, curcumin has also been shown to have in vitro and in vivo efficacy against a variety of malignancies. In the current study we examined the cytotoxic effect of curcumin on seven osteosarcoma (OS) cell lines with varying degrees of in vivo metastatic potential. Curcumin inhibited the growth of all OS cell lines tested with half-maximal inhibitory concentration values ranging from 14.4 to 24.6 μM. Growth inhibition was associated with a dose dependent increase in the number of apoptotic cells and accumulation of cells in the G2/M phase of the cell cycle. Curcumin treatment also resulted in cleavage of caspase-3 and poly adenosine diphosphate-ribose polymerase. Moreover, curcumin treatment was associated with an increase in cellular levels of the apoptotic B-cell leukemia/lymphoma 2 (Bcl-2)-associated X protein and a decrease in cellular content of the anti-apoptotic protein Bcl-2. In addition, curcumin treatment also inhibited the migration of OS cell lines. These data indicate that the potent cytotoxic activity of curcumin on OS cell lines is mediated by induction of apoptotic processes. Thus, curcumin has potential to be a novel OS chemotherapeutic agent.Keywords
This publication has 39 references indexed in Scilit:
- Taurolidine: a novel anti-neoplastic agent induces apoptosis of osteosarcoma cell linesInvestigational New Drugs, 2007
- Polymeric nanoparticle-encapsulated curcumin ("nanocurcumin"): a novel strategy for human cancer therapyJournal of Nanobiotechnology, 2007
- Curcumin: The story so farEuropean Journal of Cancer, 2005
- Bcl-2 inhibits Bax translocation from cytosol to mitochondria during drug-induced apoptosis of human tumor cellsCell Death & Differentiation, 2000
- Effect of dietary curcumin and dibenzoylmethane on formation of 7,12- dimethylbenz[a]anthracene-induced mammary tumors and lymphomas/leukemias in Sencar miceCarcinogenesis: Integrative Cancer Research, 1998
- Curcumin, an antioxidant and anti-tumor promoter, induces apoptosis in human leukemia cellsBiochimica et Biophysica Acta (BBA) - Molecular Basis of Disease, 1996
- Influence of Doxorubicin Dose Intensity on Response and Outcome for Patients With Osteogenic Sarcoma and Ewing's SarcomaJNCI Journal of the National Cancer Institute, 1991
- Pharmacology ofCurcuma longaPlanta Medica, 1991
- Oxygen radical scavenging activity of curcuminInternational Journal of Pharmaceutics, 1990
- The therapy of osteogenic sarcoma: Current status and thoughts for the futureJournal of Surgical Oncology, 1972